4//SEC Filing
Tartol John 4
Accession 0001209191-20-060365
CIK 0001180262other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 7:15 PM ET
Size
12.6 KB
Accession
0001209191-20-060365
Insider Transaction Report
Form 4
Tartol John
Director
Transactions
- Sale
Common Stock
2020-11-24$48.35/sh−1,573$76,055→ 305,886 total - Tax Payment
Common Stock
2020-11-20$48.16/sh−7,479$360,189→ 362,459 total - Exercise/Conversion
Common Stock
2020-11-20$39.79/sh+9,052$360,179→ 369,938 total - Sale
Common Stock
2020-11-23$48.83/sh−55,000$2,685,650→ 307,459 total - Exercise/Conversion
Stock Appreciation Rights
2020-11-20−9,052→ 0 totalExercise: $39.79From: 2014-04-15Exp: 2020-12-19→ Common Stock (9,052 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $48.65 to $49.05. The price reported reflects the weighted average sale price of $48.83. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 4,526 shares at an exercise price of $79.58 per share.
- [F3]The SARs were granted on December 19, 2013. 50% vested on December 19, 2013, 25% vested on January 15, 2014 and the remaining 25% vested on April 15, 2014.
Documents
Issuer
HERBALIFE NUTRITION LTD.
CIK 0001180262
Entity typeother
Related Parties
1- filerCIK 0001343530
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 7:15 PM ET
- Size
- 12.6 KB